9 questions about biohacking you were too embarrassed to ask.
Category: bioengineering – Page 153
Nature asked researchers and other stakeholders what hurdles remain before heritable gene editing could become acceptable as a clinical tool. Although some scientific challenges are probably surmountable, approval on a grand scale is likely to require changes to how clinical trials are run, as well as a broader consensus about the technology.
Efforts to make heritable changes to the human genome are fraught with uncertainty. Here’s what it would take to make the technique safe and acceptable.
Ever wonder why some fortunate people eat chips, don’t exercise, and still don’t get clogged arteries? It could be because they’ve got lucky genes.
Now Alphabet (Google’s parent company) is bankrolling a startup company that plans to use gene editing to spread fortunate DNA variations with “one-time” injections of the gene-editing tool CRISPR.
Heart doctors involved say the DNA-tweaking injections could “confer lifelong protection” against heart disease.
CRISPR genome editing is one of the most significant, world-changing technologies of our era, allowing scientists to make incredibly precise cut n’ paste edits to the DNA of living organisms. Now, one synthetic biologist from NASA plans to make it as accessible as a home science kit, so you can bio-hack yeast and bacteria on your kitchen bench.
The CRISPR gene-editing system is usually known for helping scientists treat genetic diseases, but the technology has a whole range of possible uses in synthetic biology too. Now researchers at ETH Zurich have used CRISPR to build functional biocomputers inside human cells.
AI, Immunology, and Healthcare — Professor Shai Shen-Orr PhD., Associate Professor at Technion — Israel Institute of Technology, and Founder and Chief Scientist CytoReason — ideaXme — Ira Pastor
Posted in aging, big data, bioengineering, biotech/medical, business, disruptive technology, DNA, genetics, health, life extension
Barcodes are used in a new way in the MAGESTIC platform, adding a new level of precision to CRISPR gene editing.